Patent rights or patient rights? An assessment of intellectual property and right to health within the Covid-19 pandemic / Alessandra Tisi
2021
Formats
| Format | |
|---|---|
| BibTeX | |
| MARCXML | |
| TextMARC | |
| MARC | |
| DublinCore | |
| EndNote | |
| NLM | |
| RefWorks | |
| RIS | |
Title
Patent rights or patient rights? An assessment of intellectual property and right to health within the Covid-19 pandemic / Alessandra Tisi
Author
Imprint
Venice, Italy: Global Campus of Human Rights, 2021
Language Note
English
Summary
The outburst of Covid-19 and the global unequal distribution of vaccines among the world
countries turned on again the existing tensions between the global rich, developed north and the
global south on the role played by intellectual property (IP) in relation to access to vaccines.
Their opposing positions on the issue brought to a deadlock at the WTO, where since months a
proposal on a temporary suspension of IP is being discussed with no solution in sight. In fact,
if rich developed countries consider it as the reason why vaccines got developed so fast,
developing countries sees in it the main burden towards an equitable production and roll-out of
Covid-19 vaccines.
Considering the pandemic situation and the heated debate at the WTO, this thesis will explore
the role that IP plays in relation to the right to health to check whether it enables or limit the
fulfilment of the state’s duties towards that right. My work will start from a theoretical analysis
of the international legal framework around IP, will proceed through an assessment of the
consequences deriving from its practical implementation and will end with a closer look at the
role played by IP in the actual pandemic situation, with the hope to give the reader an
encompassing perspective on the issue.
Linked Resources
Record Appears in
Language
English